Is Strong Q1 and Higher Dividend Guidance Altering The Investment Case For Nomura Research Institute (TSE:4307)?

• Nomura Research Institute, Ltd. reported first-quarter results for the period ended June 30, 2026, with year-over-year growth in sales, net income and earnings per share, while also issuing fiscal 2027 earnings guidance that includes expected revenue of ¥850,000 million and profit attributable to owners of parent of ¥119,000 million.
• The company also raised its second quarter-end dividend guidance to ¥42.00 per share, compared with ¥35.00 a year earlier, signaling management’s willingness to return more cash to shareholders alongside its updated earnings outlook.
• We’ll now assess how the stronger first-quarter earnings and higher interim dividend guidance affect Nomura Research Institute’s existing investment narrative.

AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Nomura Research Institute Investment Narrative Recap

To own Nomura Research Institute, you need to be comfortable with a consulting and IT services business that leans on consistent earnings, disciplined capital returns and technology-driven demand from financial and industrial clients. The latest first quarter beat and higher interim dividend guidance reinforce the near term earnings and payout story, while the key risk now is whether profit margins can hold up after a year when overall net margins were significantly lower than before.

The most directly relevant update here is NRI’s fiscal 2027 guidance, which sets out revenue of ¥850,000 million and profit attributable to owners of parent of ¥119,000 million. When set against the first quarter results, this guidance frames upcoming earnings releases as the main catalyst for reassessing how resilient the company’s profitability really is, especially given the previous compression in net margins.

Yet investors should also be aware that weaker margins after a prior year of lower net income could still weigh on...

Read the full narrative on Nomura Research Institute (it's free!)

Nomura Research Institute's narrative projects ¥952.6 billion revenue and ¥148.6 billion earnings by 2029. This requires 5.3% yearly revenue growth and about a ¥133.3 billion earnings increase from ¥15.3 billion today.

Uncover how Nomura Research Institute's forecasts yield a ¥5675 fair value, a 17% upside to its current price.

Exploring Other Perspectives

One Simply Wall St Community member values NRI at ¥5,075.86 per share, showing how a single viewpoint can differ from market pricing. When you set that against the recent focus on margin pressure, it underlines why it helps to compare several independent perspectives before drawing conclusions about the company’s future performance.

Explore another fair value estimate on Nomura Research Institute - why the stock might be worth as much as ¥5076!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Nomura Research Institute research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Nomura Research Institute research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Nomura Research Institute's overall financial health at a glance.

No Opportunity In Nomura Research Institute?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• The latest GPUs need a type of rare earth metal called Terbium and there are only 28 companies in the world exploring or producing it. Find the list for free.
• Find 18 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com